L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 29, Issue 6, Pages 1253-1266
Publisher
Springer Nature
Online
2014-12-08
DOI
10.1038/leu.2014.338
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells
- (2013) Célia Rosilio et al. CANCER LETTERS
- CD98hc (SLC3A2) regulation of skin homeostasis wanes with age
- (2013) Etienne Boulter et al. JOURNAL OF EXPERIMENTAL MEDICINE
- LAT1 Is a Critical Transporter of Essential Amino Acids for Immune Reactions in Activated Human T Cells
- (2013) K. Hayashi et al. JOURNAL OF IMMUNOLOGY
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation
- (2013) Linda V Sinclair et al. NATURE IMMUNOLOGY
- High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas
- (2012) Nobuyuki Yanagisawa et al. JOURNAL OF CLINICAL PATHOLOGY
- Failure of Amino Acid Homeostasis Causes Cell Death following Proteasome Inhibition
- (2012) Amila Suraweera et al. MOLECULAR CELL
- CD98 Increases Renal Epithelial Cell Proliferation by Activating MAPKs
- (2012) Nada Bulus et al. PLoS One
- Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis
- (2011) Mio Furuya et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Metabolism and Pharmacokinetic Studies of JPH203, an L-Amino Acid Transporter 1 (LAT1) Selective Compound
- (2011) Michael F. Wempe et al. Drug Metabolism and Pharmacokinetics
- Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
- (2011) Ira Tabas et al. NATURE CELL BIOLOGY
- High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions
- (2011) Masaaki Ichinoe et al. PATHOLOGY INTERNATIONAL
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- Targeting autophagy to fight hematopoietic malignancies
- (2010) Alexandre Puissant et al. CELL CYCLE
- Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
- (2010) Matthew R Janes et al. NATURE MEDICINE
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
- (2009) Koji Oda et al. CANCER SCIENCE
- Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
- (2009) Paul Nicklin et al. CELL
- Novel therapies for peripheral T-cell non-Hodgkinʼs lymphomas
- (2009) Bruce D Cheson CURRENT OPINION IN HEMATOLOGY
- Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
- (2009) W-L Zhao LEUKEMIA
- l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms
- (2008) Kyoichi Kaira et al. CANCER SCIENCE
- Tenets of PTEN Tumor Suppression
- (2008) Leonardo Salmena et al. CELL
- Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
- (2008) Wei Guo et al. NATURE
- L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
- (2008) Takeshi Sakata et al. PATHOLOGY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started